Research compound supplied in Australia by Pulse Biolabs for laboratory use. Available in 50mg, 100mg.
GHK is a short peptide found in human blood that binds copper. The copper complex, GHK-Cu, is studied for how it influences the cells that build and remodel skin and connective tissue.
GHK-Cu is the copper complex of GHK, a three-amino-acid peptide found in human plasma. It is studied for how it influences the cells that build and remodel skin and connective tissue, including collagen synthesis and broad changes in gene expression. Evidence comes from cell culture and from topical studies, including one randomised human trial of a GHK-Cu gel on diabetic foot ulcers; no controlled human trial of a systemic route was identified.
Read the full research note →| Presentation | Code | Status | Price |
|---|---|---|---|
| 50mg | GHK50 | In stock | $55 |
| 100mg | GHK100 | In stock | $100 |
2 published reports for GHK-Cu, listed by presentation and batch. Where a batch reference is shown, match it to the batch on the vial label; a report for an earlier batch is historical documentation and does not describe the batch currently supplied. Where no batch reference is published, the report cannot be matched to a vial and is historical documentation only. No report is published for 100mg. Each report describes the sample and the tests shown on it. A purity result does not by itself establish identity, quantity, sterility or endotoxin status unless those tests appear on the report, and a report for one batch does not describe another.
| Presentation | Report | Batch | |
|---|---|---|---|
| 50mg | independent laboratory report | no batch reference published (internal label: Original (Undated),) | Open |
| 50mg | independent laboratory report | B.3.26 | Open |
Supplied as lyophilised (freeze-dried) powder in a sealed vial. Store sealed and protected from light at the conditions stated on the product label or supplied specification. Solvent choice, concentration and handling after reconstitution depend on the compound and on the laboratory’s own procedures, and are not specified here.
GHK-Cu is not an approved medicine in Australia; the TGA names it among unapproved peptide products in its advisory on importing, compounding and supplying such products. No regulator-approved GHK-Cu medicine was identified for this note; the peptide appears in cosmetic products, which are regulated differently from medicines.
Status checked 2026-09-23. Details and sources in the research note.